Free Trial

Terns Pharmaceuticals (TERN) Insider Trading & Ownership

Terns Pharmaceuticals logo
$6.17 -0.38 (-5.80%)
(As of 11/15/2024 ET)

Terns Pharmaceuticals (NASDAQ:TERN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.00 M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$2.96 M
Get TERN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Terns Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TERN Insider Buying and Selling by Quarter

Terns Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00  
9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.00  
9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.00  
8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.24  
7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00  
4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20  
4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83  
(Data available from 1/1/2013 forward)

TERN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Terns Pharmaceuticals includes Biosciences Fund V L.P. Lav, Carl L Gordon, Hongbo Lu, Jill M Quigley, Mark J Vignola, Orbimed Advisors Llc, and Vivo Opportunity, Llc. Learn more on insiders at TERN.

15.10% of Terns Pharmaceuticals stock is owned by insiders. Learn more on TERN's insider holdings.

The following insiders have purchased TERN shares in the last 24 months: Hongbo Lu ($4,999,995.00), Orbimed Advisors Llc ($999,999.75), and Vivo Opportunity, Llc ($5,499,995.00).

Insiders have purchased a total of 1,372,741 TERN shares in the last 24 months for a total of $11,499,989.75 bought.

The following insiders have sold TERN shares in the last 24 months: Biosciences Fund V L.P. Lav ($8,250,000.00), Carl L Gordon ($509,760.00), Jill M Quigley ($219,528.24), Mark J Vignola ($110,000.00), and Vivo Opportunity, Llc ($2,122,017.03).

Insiders have sold a total of 1,903,537 Terns Pharmaceuticals shares in the last 24 months for a total of $11,211,305.27 sold.

Terns Pharmaceuticals Key Executives

  • Dr. Erin Quirk M.D. (Age 53)
    President & Head of Research & Development
    Compensation: $1.06M
  • Dr. Mark Joseph Vignola Ph.D. (Age 46)
    CFO & Treasurer
    Compensation: $974.16k
  • Mr. Seokho Yoon Esq. (Age 46)
    COO, General Counsel & Secretary
    Compensation: $921.05k
  • Ms. Amy L. Burroughs M.B.A. (Age 53)
    CEO & Director
  • Dr. Jeffrey R. Jasper Ph.D.
    Senior VP & Head of Research
  • Dr. Emil T. Kuriakose M.D. (Age 44)
    Chief Medical Officer
  • Ms. Melita Sun Jung (Age 47)
    Chief Business Officer


This page (NASDAQ:TERN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners